ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,937 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZugTanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug
Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of Mitsubishi Tanabe Pharma GmbH is the research, development and marketing of pharmaceuticals, particularly in the areas of autoimmune diseases, diabetes and kidney diseases. The focus is on marketing specific medications such as Argatra (Argatroban monohydrate) and RADICAVA (Edaravone) in Germany, Austria and Switzerland.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered3
Medicines
High-quality medicines from our own research, with a focus on the hospital market and marketing in Switzerland.
Research and development of medicines
Research and development of medicines with therapeutic added value, in collaboration with scientists and partners worldwide.
Marketing of medicines
Marketing of new medicines and therapy options, currently in particular RADICAVA® (Edaravone) in Switzerland.
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.7/5

Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug

Trust & reputation

ranQ Trust Score of Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug: 3.7 out of 5.0

Trust Score3.7/ 5.0

Solid

x

Data basis 96% · As of October 2026

Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug scores 59.6 out of 100 points in the Reputation area of the ranQ Trust Score. This area carries 42% of the weighting.
x
CriterionValueWeight
  • Review quality: The average rating across all connected sources, smoothed against the industry mean. So 5.0 stars from three reviews do not outrank 4.7 from three hundred.66.724%
  • Review volume: The number of reviews across all sources. The scale is logarithmic: the first reviews count the most, and the maximum is reached at 50 reviews.27.910%
  • Review recency: The age of the most recent review. Two-year-old reviews deliberately sit in the middle, because that is normal for Swiss SMEs. Only after three years without a new voice does the value drop markedly.78.08%
Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug scores 53.9 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.39.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug scores 62.9 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.62.94%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug reaches a ranQ Trust Score of 3.7 out of 5.0 — rated «Solid». The rating draws, among other things, on 4.5 out of 5 stars from 2 customer reviews. The data basis is 96%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Reviews

Aggregated rating

Aggregated rating
4.5
of 5

Aggregated from 2 reviews across all connected sources

Sources
GGoogle4.52
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Knowledge

No knowledge articles yet

Once Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Tanabe Pharma GmbH, Düsseldorf, Zweigniederlassung Zug to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Baarerstrasse 14
6300 Zug
Opening hours
Mon
08:00 - 20:00
Tue
08:00 - 20:00
Wed
08:00 - 20:00
Thu
08:00 - 20:00
Fri
08:00 - 20:00
Sat
08:00 - 20:00
Sun
08:00 - 20:00

At a glance

Legal form
Foreign branch
UID
CHE-462.359.972
Founded
2024 · 2 years
Last commercial register change
January 29, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.73.06%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    IP
    IPSEN Pharma Schweiz GmbH
    Zug
    NT
    Nektar Therapeutics Europe GmbH
    Zug
    OS
    ORACTIVE SWISS AG
    Zug
    DP
    Deciphera Pharmaceuticals (Schweiz) AG
    Zug
    QP
    Quercis Pharma AG
    Zug
    NG
    Neopharmed Gentili Schweiz GmbH
    Zug
    IS
    Insmed Switzerland GmbH
    Zug
    HP
    Helvion Pharma AG
    Zug